MOH — authorised 29 May 1997
- Marketing authorisation holder: PROSTRAKAN INC
- Status: likely_approved
MOH authorised Fareston on 29 May 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 29 May 1997.
PROSTRAKAN INC holds the UAE marketing authorisation.